Increased receptor activator of nuclear factor κβ ligand/osteoprotegerin ratio exacerbates cartilage destruction in osteoarthritis in vitro.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3892/ETM.2016.3638PMID 27698783PMCID PMC5038380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Origin and function of cartilage stem/progenitor cells in osteoarthritis

  2015cited by this paper
• Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis.

  2015cited by this paper
• Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond

  2014cited by this paper
• Osteoarthritis year in review 2014: mechanics--basic and clinical studies in osteoarthritis.

  2014cited by this paper
• Expression of the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta in the serum, cartilage and subchondral bone of patients with osteoarthritis.

  2013cited by this paper
• Osteoarthritis: histology and pathogenesis

  2013cited by this paper
• Historically significant events in the discovery of RANK/RANKL/OPG.

  2013cited by this paper
• The expression of RANKL and OPG in the various grades of osteoarthritic cartilage

  2012cited by this paper
• Proteases involved in cartilage matrix degradation in osteoarthritis.

  2012cited by this paper
• Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells.

  2011cited by this paper
• Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis

  2010cited by this paper
• Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis.

  2010cited by this paper
• Investigation of relative micromotion at the stem—cement interface in total hip replacement

  2009cited by this paper
• Femoral stem wear in cemented total hip replacement

  2008cited by this paper
• The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.

  2008cited by this paper
• Joint diseases and matrix metalloproteinases: a role for MMP-13.

  2008cited by this paper
• Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis.

  2007cited by this paper
• Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis.

  2006cited by this paper
• Osteoarthritis cartilage histopathology: grading and staging.

  2006cited by this paper
• Matrix metalloproteinases: role in arthritis.

  2006cited by this paper
• Matrix metalloproteinases (MMPs) in health and disease: an overview.

  2006cited by this paper
• Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta.

  2005cited by this paper
• The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.

  2004cited by this paper
• Defective bone remodelling in osteoprotegerin-deficient mice.

  2003cited by this paper
• Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls.

  2003cited by this paper
• Role of RANKL and RANK in bone loss and arthritis

  2002cited by this paper
• The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis

  1999cited by this paper
• Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint.

  1998cited by this paper
• Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study.

  1998cited by this paper

• Platelet-rich plasma ameliorates cartilage degradation in rat models of osteoarthritis via the OPG/RANKL/RANK system.

  2024cites this paper
• Electroactive Biomaterials for Facilitating Bone Defect Repair under Pathological Conditions

  2022cites this paper
• The role of indoleamine 2,3 dioxygenase 1 in the osteoarthritis.

  2020cites this paper
• Serum FGF-2 and RANKL are biological indicators for the diagnosis of osteoarthritis

  2020cites this paper
• Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis

  2019cites this paper